Wang et al. reported that the Cas9 protein-encoded mRNA is co-delivered with gRNAs that target legumain (LGMN) genes, which are known to cause various diseases, including cancer, effectively suppressing the metastatic properties of breast cancer [228]. This evidence concerns the gene LGMN and cancer.